Summary.-The growth of carcinoma of the human large bowel was studied in the first 2 passages in immune deprived mice. The tumours were obtained from large bowel resections on 3 people. There was a strong histological similarity between the patient's tumour and the tumour that grew subcutaneously in the mice 2-8 months after implantation. One dissimilarity observed was a higher mitotic index in some of the tumours growing in the immune deprived animals. In the second passage of the bowel tumours, cells were implanted into groups of 8-10 animals in the following sites: subcutaneous, intramuscular, intravenous, intrahepatic, intraperitoneal and intrathoracic. Growth of tumour was observed from all 3 tumours when they were implanted subcutaneously, intramuscularly, intraperitoneally and intrathoracically. Infiltration of muscle by tumour was a frequent finding. Lung metastases developed after intravenous injection of cells in 1 of the 3 tumours. In none of the 3 tumours did growth follow injection of cells directly into the substance of the liver. On no occasions were spontaneous metastases observed.
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CARCINOMA arising in the large bowel in man can be transplanted successfully subcutaneously in immune deprived animals (Povlsen and Rygaard, 1971; Castro, 1972; Cobb, 1972) . If we wish to use this xenograft model to learn more about a tumour in man, we need to understand to what extent transplantation to a xenogeneic host alters the tumour cell population. The work described in this article was designed to study the changes likely to occur when carcinoma of the large bowel is transplanted into immune deprived mice and, in addition, when this first passage tumour population is transplanted into a further group of immune deprived mice. The study of the second passage was instituted because occasions could be foreseen when insufficient of the primary tumour would be available to carry out all studies on the first passage.
In the present study passage 1 of the tumour was only carried subcutaneously, using a small amount of primary (patient's) tumour. When the tumour material had grown to a sufficient volume it was prepared for a second passage; on this occasion the tumour was implanted subcutaneously, intramuscularly, intravenously, intrahepatically and by injection into the pleural and peritoneal cavities. The results, in terms of tumour growth and invasiveness, are recorded below and the subsequent discussion is concerned with the problems of interpreting the behaviour of the tumour in mice in terms of its likely behaviour had those cells been allowed to remain in the human host. On admission to hospital she had a large pelvic mass and was very anaemic. At laparotomy a partial colectomy was performed for carcinoma of the colon. Because of involvement of other organs it was necessary to carry out partial ileectomy and partial cystectomy. The patient died 2 months later from bronchopneumonia and recurrent carcinoma of the colon. The tumour removed at operation was a poorly differentiated adenocarcinoma. There was infiltration of the wall of the large and small intestine and of the bladder. Therewasinvasion bytumour of lymphatic vessels and veins. The regional lymph nodes were also involved with tumour.
Patient R.G. (Tumour number P116).-
The patient was a 65-year old male who had complained of pain and swelling of the abdomen for 2 months. Diarrhoea had been intermittent but without blood. A left hemicolectomy was performed for adenocarcinoma of the colon. The tumour was a well differentiated, mucus producing, adenocarcinoma and had metastasized to the regional lymph node. Two years later (June, 1973) " was recorded when the extent of tumour growth necessitated the destruction of the animal, except in the case of intravenous injection of cells when " takes " were recorded when there was macroscopic and/or microscopic evidence of one or more lung metastases at the termination of the experiment.
The viability of cells was assessed microscopically by their ability to resist staining with nigrosin (Kaltenbach, Kaltenbach and Lyons, 1958) .
Second tumour passage in animals
The first mouse to bear a tumour of 10 cm3 in passage 1 of each of the 3 implanted tumours (P76, P116, P184) supplied all the tumour tissue for the study of the second passage of tumour (passage 2). Either pieces of tumour, or a cell suspension of tumour, from these 3 mice were implanted into groups of 8, 9, or 10 immune deprived mice by one of the following routes: subcutaneous, intramuscular, intrahepatic, intravenous, intraperitoneal or intrapleural (intrathoracic) (Table II) Bacteriological study.-Tissue adjacent to those areas of tumour selected for transplantation in all experiments were smeared onto blood agar plates and incubated aerobically for 72 hours.
RESULTS
Behavioar of P76 in immune deprived mice The tumour grew progressively in 2 of the 8 immune deprived mice into which pieces of the primary tumour were implanted (Table I) . After 3 months the most rapidly growing tumour had reached an estimated volume of 10 cm3 and this tumour material was used for the passage 2 studies. The tumour in the second mouse did not reach 10 cm3 until 8 months after implantation. The histological appearance of tumour removed from the 2 mice closely resembled that of the patient's tumour. Many areas of the tumour in the mice were indistinguishable histologically from the primary tumour in the patient. The mitotic index of the tumour material from the mouse was noticeably higher than the mitotic index in the patient's tumour (Table I) . The tumour growing subcutaneously in the mice had infiltrated and destroyed areas of the subcutaneous muscle and in one animal this led to ulceration of the skin (Fig. 1) . There was no evidence of infiltration of lymphatic vessels or blood vessels by the tumour in the mouse, although this had been the case in the primary tumour when growing in the patient.
In the second generation of subcutaneous passage in mice (passage 2) 8 of the 10 implanted mice grew tumours (Table II) . The first tumour to grow to 10 cm3 did so 2 months after the implantation of a 9 mm3 piece of tumour. The histological appearance was similar to the tumour of passage 1 with a similar mitotic index (Table I ). There was infiltration by the tumour of the underlying abdominal muscle (Fig. 2) by tumour. The tumour implanted into the muscle of the hind limb grew in all animals, illustrating clearly the ability of the tumour to grow and to infiltrate striated muscle in the mouse. Tumour was not observed in the regional lymph nodes of the hind limbs.
Behaviour of P116 in immnune deprived mice The tumour implanted into 5 immune deprived mice grew progressively in 3 of the animals and grew for only a short period, before regressing, in the other 2 animals ( Table I ). The growth of tumour and subsequent regression in these 2 animals was assessed only by palpation; a biopsy was not taken to confirm the presence of tumour. In the 3 mice in which the tumour grew progressively the histology was that of a well differentiated, mucus secreting adenocarcinoma of the colon. Its appearance was very similar to the primary tumour in the patient (Fig. 3 and 4) . The tumour growing in the mice appeared to have greater lymphocyte infiltration than did the patient's tumour although the difference was marginal. As with P76, the mitotic index of passage 1 of P116 in the mice was significantly higher than in the patient (Table  I) . Passage 2 of P116 in the mice grew in 10 out of 10 subcutaneously implanted animals (Table II) . The tumour reached a volume of 10 cm3 in some of the 10 mice more quickly in passage 2 than in passage 1. However, the extensive formation of mucin and the resultant uncertainty of the exact cellular content of the implanted tumour pieces made measurement of tumour volume and estimation of tumour volume doubling time of little value. The subcutaneous and intramuscular growth of passage 2 showed the ability of this tumour to infiltrate adjacent muscle.
The tumour grew well when injected as a cell suspension intrapleurally and intraperitoneally. Attachment was predominantly to the parietal pleura and diaphragm in the thorax and to the visceral peritoneum, particularly the omentum in the abdomen. It was not possible to obtain growth of the tumour by injection of 2 x 105 live cells into the substance of the liver. In 4 of the 10 mice receiving 2 x 105 cells intravenously, scattered lung metastases were observed macroscopically when the 10 mice were killed 9 months after the intravenous injection of the cells. The metastases appeared microscopically as small groups of well differentiated adenocarcinoma cells suspended in mucin (Fig. 5) sites for the implantation of tumour. On occasions abdominal organs had attached tumour masses but these organs were never observed to be infiltrated by the tumour.
ChroMosome analysis The chromosome analysis of tumour from passage 2 of P76 showed the tumour cells to be unequivocally of human origin.
DISCUSSION
There can be little doubt that carcinoma of the large bowel, when transplanted into immune deprived animals, will provide a useful method for the study of this tumour. The clinical value will be related to the similarity of the tumour in the animals to the tumour in the patient. There was little difficulty in establishing growth of passage 2 of the 3 tumours in the subcutaneous, intramuscular, intraperitoneal and intrapleural sites. It is not possible from the results to suggest which of these 4 sites is likely to be the most efficient in the support of implanted large bowel tumour from patients.
The criterion for tumour " take " in the present experiments was the development of a relatively large tumour mass, approximately one quarter of the total body weight. On occasions, masses were observed at the site of implantation which regressed before reaching the size required to register a " take ". The size of 10 cm3 was chosen to be the minimum necessary to register a " take" because it was known that once a tumour had reached these dimensions it would not regress spontaneously.
Carcinoma of the large bowel in man has usually infiltrated the muscularis mucosae and the muscle of the bowel wall by the time it is observed clinically. It was interesting to note that infiltration of the subcutaneous muscle and the muscle of the abdominal wall was observed in the first and second passages of the 3 tumours. The least differentiated tumour (P76) also infiltrated the dermis and produced skin ulceration. The fraction of tumour " takes " in passage 2 was greater than in passage 1 for all 3 tumours. This increase may have been due to a higher percentage of cells with clonogenic capacity being present in the tumours implanted on the second passage. This increased percentage of cells with clonogenic capacity would be above the threshold of cell number necessary to establish the graft. Alternatively, the presence of human stroma in the initial implant from the patient could have increased the likelihood of graft rejection. It is also possible that the implanted tumour material from the patient carried infection not registered on blood agar uinder aerobic conditions. If transplantation of tumour from the patient into the mouse were to lead to selection of those cells that will grow most easily and proliferate most rapidly in the mouse, then it might be expected that implantation of such tissue would be more successful in the second passage where they will form a higher percentage of the inmplanted cells.
Volume doubling time was estimated at the commencement of these experiments but after the initial histology revealed that P116 was approximately 95%0 mucin and 5% tumour tissue, it was realized that simply measuring external diameter of the tumour mass would not only represent changes in tumour population but also changes in the balance of mucin production and absorption, and so estimations of tumour volume doubling time were abandoned.
In conclusion, it is apparently possible to obtain progressive expansion of a tumour cell population of carcinoma of the human large bowel in immune deprived mice. Areas of the tumour in the mice have a close histological resemblance to the primary tumour in the patient. However, there are also apparent differences in tumour structure, invasiveness and mitotic indices and caution should be exercised before using the tumour growing in immune deprived mice as a replica of the tumour remaining in the patient. 
